Company news
Assertio Holdings, Inc. news in 2020
Assertio Holdings, Inc.'s news releases, calls and decks from 2020, newest first.
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market
December 28, 2020
Assertio Announces Restructuring Plan and Leadership Changes
December 14, 2020
Assertio Reports Third Quarter 2020 Financial Results
November 5, 2020
Assertio to Release Third Quarter 2020 Financial Results and Host Webcast on November 6, 2020
October 22, 2020
Assertio Reports Second Quarter 2020 Financial Results
August 6, 2020
Assertio to Release Second Quarter 2020 Financial Results and Host Webcast on August 7, 2020
July 19, 2020
Assertio Therapeutics Announces First-Quarter 2020 Results
May 10, 2020
Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/Prospectus
April 19, 2020
Assertio Therapeutics Announces Completion and Final Results of the Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes due 2021 and 5.00% Senior Convertible Notes due 2024
April 7, 2020
Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products
March 15, 2020
Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024
March 10, 2020
Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2019 Financial Results
March 8, 2020
Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt
February 18, 2020
Assertio Therapeutics Announces Closing of Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
February 12, 2020
Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million
February 5, 2020
Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance
January 12, 2020
Decks in 2020
- Investor Presentation (September 2020)
Investor deck · 23 slides · Sep 14, 2020
- Assertio Therapeutics — Merger or Acquisition (March 2020)
Merger or acquisition · 17 slides · Mar 17, 2020